Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan

QJM. 2020 Nov 1;113(11):785-786. doi: 10.1093/qjmed/hcaa182.

M Takita¹, T Matsumura¹, K Yamamoto^{1

2

3}, E Yamashita², K Hosoda⁴, T Hamaki², E Kusumi^{1

2}

¹ From the Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo 190-0023, Japan.
² Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo 160-0022, Japan.
³ Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo 108-0071, Japan.
⁴ Department of Pediatrics, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tachikawa, Tokyo 190-0023, Japan.

No abstract available

Publication types